News
It is no secret that the UK’s National Health Service (NHS), like many other healthcare systems, is under pressure on ...
Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...
A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.
Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...
The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.
Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...
A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...
Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...
Vivasure Medical has submitted an application seeking premarket approval from the FDA for its PerQseal Elite vascular closure ...
Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...
Experts at HLTH Europe discussed how to ensure patients have trust in the EHDS to ensure a successful roll-out.
ExoStat Medical has completed an intensive care unit (ICU) observational septic shock study of its MicroTREND System.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results